Comerica Bank
CAI

Comerica Bank’s Caris Life Sciences CAI Stock Holding History

Comerica Bank’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$18.6K Buy
689
+27
+4% +$760 ﹤0.01% 3106
2025
Q3 		$20K Buy
+662
New +$21.1K ﹤0.01% 3090

Other funds holding CAI

JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $326M AUM
SSP
Sixth Street Partners Dallas, Texas $711M AUM 9.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Comerica Bank's CAI Position: Q4 2025 in Review

Comerica Bank increased its Caris Life Sciences (CAI) stake by 4.1% in Q4 2025, buying an estimated $760 and bringing the position to 689 shares worth $18.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3106.

Comerica Bank first reported a position in CAI in Q3 2025 and has held it in 2 quarters since. The position peaked at $20K in Q3 2025. 186 funds tracked by Wall St. Rank hold CAI as of Q4 2025.

  • Comerica Bank held 689 shares of Caris Life Sciences worth $18.6K as of Q4 2025.
  • Comerica Bank bought 27 Caris Life Sciences shares in Q4 2025, an estimated $760.
  • Caris Life Sciences made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #3106 holding.
  • Comerica Bank first reported a position in Caris Life Sciences in Q3 2025 and has held it in 2 quarters since.
  • Comerica Bank's Caris Life Sciences position peaked at $20K in Q3 2025.
  • 186 funds tracked by Wall St. Rank held Caris Life Sciences as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.